Indirubin-5-Sulphonate API Manufacturers & Suppliers

Indirubin-5-sulphonate (CAS number 244021-67-8) is a chemical compound classified within the indolines, a group of organic molecules characterized by the presence of an indole moiety. The indole structure comprises a pyrrolidine ring fused to a benzene ring, forming 2,3-dihydroindole. This structural class is notable for its relevance in various bioactive molecules.

Currently, Indirubin-5-sulphonate remains an experimental compound with no established clinical indications or approved therapeutic uses. As such, its pharmacodynamics and mechanism of action have not been comprehensively characterized in the literature or regulatory databases. The absence of detailed pharmacological data limits the ability to define its potential clinical application or target pathways.

Information regarding absorption, distribution, metabolism, and excretion (ADME) of Indirubin-5-sulphonate is not readily available. Without such data, predicting its bioavailability, metabolic transformations, or clearance pathways remains speculative. Safety and toxicity profiles have similarly not been established through clinical or preclinical studies, necessitating caution in experimental use and further investigation to determine any adverse effects or risk parameters.

As an experimental compound, Indirubin-5-sulphonate may be utilized primarily within research contexts, such as structure-activity relationship studies or as a chemical probe to explore indole-related biological mechanisms.

For API sourcing and procurement, considerations should include verification of chemical purity, batch consistency, and compliance with relevant pharmacopoeial or regulatory standards where applicable. Suppliers should provide complete characterization data, including impurity profiles and stability information, to support quality assurance in research or development settings. Given the lack of clinical application, sourcing is typically limited to specialized chemical manufacturers or research-grade suppliers.